PUBLISHER: Lucintel | PRODUCT CODE: 1386337
PUBLISHER: Lucintel | PRODUCT CODE: 1386337
The future of the global cardiac rhythm management devices market looks promising with opportunities in the hospital & clinic and ambulatory surgery center markets. The global cardiac rhythm management devices market is expected to reach an estimated $19.3 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are rising prevalence of cardiovascular diseases, growing awareness towards the benefits of cardiac rhythm management devices, and on-going technological advancements are resulting in development of new and innovative devices that are more effective and less invasive.
A more than 150-page report is developed to help in your business decisions.
The study includes a forecast for the global cardiac rhythm management devices by product type, end use, and region.
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cardiac rhythm management devices companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cardiac rhythm management devices companies profiled in this report include-
Lucintel forecasts that defibrillators will remain the largest segment over the forecast period due to the rising prevalence of out-of-hospital cardiac arrests.
Within this market, hospitals and clinics is expected to remain the largest segment.
North America will remain the largest region due to surge in elderly population and presence of advanced healthcare system in the region.
Market Size Estimates: Cardiac rhythm management devices market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Cardiac rhythm management devices market size by product type, end use, and region in terms of value ($B).
Regional Analysis: Cardiac rhythm management devices market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, end uses, and regions for the cardiac rhythm management devices market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cardiac rhythm management devices market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Answer: The global cardiac rhythm management devices market is expected to reach an estimated $19.3 billion by 2030.
Answer: The global cardiac rhythm management devices market is expected to grow with a CAGR of 4.5% from 2024 to 2030.
Answer: The major drivers for this market are rising prevalence of cardiovascular diseases, growing awareness towards the benefits of cardiac rhythm management devices, and on-going technological advancements are resulting in development of new and innovative devices that are more effective and less invasive.
Answer: The future of the cardiac rhythm management devices market looks promising with opportunities in the hospital & clinic and ambulatory surgery center markets.
Answer: Some of the key cardiac rhythm management devices companies are as follows:
Answer: Lucintel forecasts that defibrillators will remain the largest segment over the forecast period due to the rising prevalence of out-of-hospital cardiac arrests.
Answer: North America will remain the largest region due to surge in elderly population and presence of advanced healthcare system in the region.
Answer: Yes, Lucintel provides 10% customization without any additional cost.